ZA9781B - Resolution of galanthamine. - Google Patents
Resolution of galanthamine.Info
- Publication number
- ZA9781B ZA9781B ZA9700081A ZA9781A ZA9781B ZA 9781 B ZA9781 B ZA 9781B ZA 9700081 A ZA9700081 A ZA 9700081A ZA 9781 A ZA9781 A ZA 9781A ZA 9781 B ZA9781 B ZA 9781B
- Authority
- ZA
- South Africa
- Prior art keywords
- galanthamine
- pct
- date jul
- enantiomerically
- sec
- Prior art date
Links
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 title abstract 9
- HPOIPOPJGBKXIR-UHFFFAOYSA-N 3,6-dimethoxy-10-methyl-galantham-1-ene Natural products O1C(C(=CC=2)OC)=C3C=2CN(C)CCC23C1CC(OC)C=C2 HPOIPOPJGBKXIR-UHFFFAOYSA-N 0.000 title abstract 4
- LPCKPBWOSNVCEL-UHFFFAOYSA-N Chlidanthine Natural products O1C(C(=CC=2)O)=C3C=2CN(C)CCC23C1CC(OC)C=C2 LPCKPBWOSNVCEL-UHFFFAOYSA-N 0.000 title abstract 4
- 229960003980 galantamine Drugs 0.000 title abstract 4
- BGLNUNCBNALFOZ-WMLDXEAASA-N galanthamine Natural products COc1ccc2CCCC[C@@]34C=CCC[C@@H]3Oc1c24 BGLNUNCBNALFOZ-WMLDXEAASA-N 0.000 title abstract 4
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 title abstract 4
- IYVSXSLYJLAZAT-NOLJZWGESA-N lycoramine Natural products CN1CC[C@@]23CC[C@H](O)C[C@@H]2Oc4cccc(C1)c34 IYVSXSLYJLAZAT-NOLJZWGESA-N 0.000 title abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 238000002425 crystallisation Methods 0.000 abstract 1
- 230000008025 crystallization Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Glass Compositions (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9600080.7A GB9600080D0 (en) | 1996-01-04 | 1996-01-04 | Resolution process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9781B true ZA9781B (en) | 1998-01-06 |
Family
ID=10786571
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9700081A ZA9781B (en) | 1996-01-04 | 1997-01-06 | Resolution of galanthamine. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6087495A (de) |
| EP (1) | EP0880525B1 (de) |
| AT (1) | ATE227725T1 (de) |
| AU (1) | AU700997B2 (de) |
| CA (1) | CA2239814C (de) |
| DE (1) | DE69717076T2 (de) |
| DK (1) | DK0880525T3 (de) |
| ES (1) | ES2186862T3 (de) |
| GB (1) | GB9600080D0 (de) |
| PT (1) | PT880525E (de) |
| WO (1) | WO1997025330A1 (de) |
| ZA (1) | ZA9781B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2310926C (en) * | 2000-04-03 | 2002-10-15 | Janssen Pharmaceutica N.V. | A use of galantamine for the treatment of neuropsychiatric behaviour associated with alzheimer's disease |
| US20050142193A1 (en) * | 2003-12-31 | 2005-06-30 | Lijuan Tang | Galantamine formulations |
| US20050191349A1 (en) * | 2003-12-31 | 2005-09-01 | Garth Boehm | Galantamine formulations |
| WO2006013546A2 (en) * | 2004-07-28 | 2006-02-09 | Ranbaxy Laboratories Limited | Process for the preparation of pure galantamine |
| CN102050826B (zh) * | 2010-12-21 | 2012-11-14 | 浙江工业大学 | 一种分离加兰他敏的方法 |
| US9309334B2 (en) | 2014-01-15 | 2016-04-12 | Exxonmobil Chemical Patents Inc. | Propylene-based impact copolymers |
| US11370902B2 (en) | 2017-09-11 | 2022-06-28 | Exxonmobil Chemical Patents Inc. | Articles comprising polypropylene impact copolymers and methods of making the same |
| CN116157429A (zh) | 2020-07-17 | 2023-05-23 | 埃克森美孚化学专利公司 | 具有低水平挥发性有机化合物的聚合物和制备此类聚合物的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5428159A (en) * | 1994-04-08 | 1995-06-27 | Ciba-Geigy Corporation | Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine |
-
1996
- 1996-01-04 GB GBGB9600080.7A patent/GB9600080D0/en active Pending
-
1997
- 1997-01-06 WO PCT/GB1997/000023 patent/WO1997025330A1/en not_active Ceased
- 1997-01-06 DE DE69717076T patent/DE69717076T2/de not_active Expired - Lifetime
- 1997-01-06 ES ES97900276T patent/ES2186862T3/es not_active Expired - Lifetime
- 1997-01-06 CA CA002239814A patent/CA2239814C/en not_active Expired - Lifetime
- 1997-01-06 EP EP97900276A patent/EP0880525B1/de not_active Expired - Lifetime
- 1997-01-06 PT PT97900276T patent/PT880525E/pt unknown
- 1997-01-06 ZA ZA9700081A patent/ZA9781B/xx unknown
- 1997-01-06 US US09/101,174 patent/US6087495A/en not_active Expired - Lifetime
- 1997-01-06 DK DK97900276T patent/DK0880525T3/da active
- 1997-01-06 AU AU13867/97A patent/AU700997B2/en not_active Expired
- 1997-01-06 AT AT97900276T patent/ATE227725T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997025330A1 (en) | 1997-07-17 |
| CA2239814A1 (en) | 1997-07-17 |
| AU1386797A (en) | 1997-08-01 |
| EP0880525B1 (de) | 2002-11-13 |
| US6087495A (en) | 2000-07-11 |
| DE69717076D1 (de) | 2002-12-19 |
| ATE227725T1 (de) | 2002-11-15 |
| GB9600080D0 (en) | 1996-03-06 |
| PT880525E (pt) | 2003-03-31 |
| CA2239814C (en) | 2006-08-29 |
| DE69717076T2 (de) | 2003-07-17 |
| AU700997B2 (en) | 1999-01-14 |
| DK0880525T3 (da) | 2003-03-03 |
| EP0880525A1 (de) | 1998-12-02 |
| ES2186862T3 (es) | 2003-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG102474A (en) | (-)-cis-6(s)-phenyl-5(r)-[4-(2-pyrrolidine-1-yletoxi)phenyl)-5,6,7 ,8-tetrahydronaphthalen-2-ol-d-tartarate | |
| GR3036305T3 (en) | Chiral methyl phenyl oxazolidinones | |
| ZA974216B (en) | Process for the resolution of racemic ketamine. | |
| ZA9781B (en) | Resolution of galanthamine. | |
| MY129130A (en) | (+)-norcisapride | |
| BG103649A (en) | Method for the preparation of eprosartan | |
| BG103650A (en) | Method for the preparation of eprosartan | |
| ZA963132B (en) | Process for the preparation of pure enantiomers of 1-2-pyridyl)-2-cyclo-hexylethylamine. | |
| GB9614804D0 (en) | Resolution process | |
| IL132623A0 (en) | Process for making 2-(trihaloacetyl)-3-(substituted amino)-2-propenoates | |
| HUP9901713A3 (en) | Process for the production of enantiomerically-pure azetidine-2-carboxylic acid | |
| AU694653B2 (en) | D4T polymorphic form I process | |
| MY103910A (en) | 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof | |
| GB9318790D0 (en) | Heterocyclic derivatives | |
| AU3055397A (en) | Heterocyclic compounds | |
| AU5764096A (en) | Process for producing 5,6-dihydro-1,3-oxazines | |
| HUP0001926A3 (en) | A process for the crystallization of lactitol | |
| ZA963192B (en) | Process for making heterocyclic compounds. | |
| GR3032175T3 (en) | IMPROVED SYSTEM FOR THE TRANSDERMAL APPLICATION OF PHARMACOLOGICALLY ACTIVE COMPOUNDS AT CONTROLLED pH. | |
| HU9200864D0 (en) | Process for the diastereo-selective reductive pinkole joining of homokyral alphaaminoaldehides | |
| ZA961044B (en) | New pyridine and pyridazine derivatives, processes for the production thereof and pharmaceutical agents containing these compounds. | |
| SE9404438D0 (sv) | New process | |
| EG20542A (en) | Process for preparing of benzopyrons compounds | |
| FR2685330B1 (fr) | Procede de preparation des enantiomeres d'un derive de l'isoindolinone. | |
| FR2708203B1 (fr) | Procédé d'inhibition de la perception des odeurs. |